The Optimal Dosing and Timing of Tranexamic Acid in Reducing Perioperative Bleeding and Transfusion Requirements in Vascular Surgery Patients: A Systematic Review

Tranexamic acid (TXA) has been widely investigated as an antifibrinolytic agent to minimize perioperative bleeding and transfusion requirements in various surgical settings. This systematic review aims to assess the optimal dosing and timing of TXA administration for reducing perioperative bleeding...

Descripción completa

Detalles Bibliográficos
Autor principal: Turaga, Anjani H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiac/Thoracic/Vascular Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516444/
https://www.ncbi.nlm.nih.gov/pubmed/37746423
http://dx.doi.org/10.7759/cureus.43947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516444/
https://www.ncbi.nlm.nih.gov/pubmed/37746423
http://dx.doi.org/10.7759/cureus.43947

Ejemplares similares